Affymetrix is facing a lawsuit related to its imminent purchase of eBioscience. The firm has also pushed back the anticipated completion period for the deal, but said that the delay is not related to the new suit.

Tang Capital Partners, a San Diego-based investment fund, on Dec. 29, 2011, filed class action litigation in the Superior Court of California in the County of Santa Clara, Affy said last week in a filing with the US Securities and Exchange Commission.

The court does not make civil case documents available online.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

In PLOS this week: GWAS links gene to noise-induced hearing loss in mice, population genetics of malaria parasites, and more.

Nautilus' Alexandra Ossola examines how Tay-Sachs disease jump-started the genetic disease testing field.

FASEB says guidelines proposed by the NIH to bolster research reproducibility are premature and don't take the full range of scientific studies into consideration.

Liquid biopsies and DNA tests may be able to tell physicians whether a cancer patient is relapsing, the New York Times reports.